Tocqueville Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-20,016
| Closed | -$2.75M | – | 535 |
|
2024
Q2 | $2.75M | Hold |
20,016
| – | – | 0.05% | 234 |
|
2024
Q1 | $2.75M | Sell |
20,016
-145
| -0.7% | -$19.9K | 0.04% | 240 |
|
2023
Q4 | $2.74M | Buy |
20,161
+145
| +0.7% | +$19.7K | 0.05% | 228 |
|
2023
Q3 | $2.45M | Hold |
20,016
| – | – | 0.05% | 237 |
|
2023
Q2 | $2.54M | Hold |
20,016
| – | – | 0.05% | 242 |
|
2023
Q1 | $2.59M | Sell |
20,016
-46
| -0.2% | -$5.94K | 0.05% | 246 |
|
2022
Q4 | $2.63M | Buy |
20,062
+46
| +0.2% | +$6.04K | 0.05% | 253 |
|
2022
Q3 | $2.34M | Hold |
20,016
| – | – | 0.05% | 264 |
|
2022
Q2 | $2.35M | Sell |
20,016
-229
| -1% | -$26.9K | 0.04% | 295 |
|
2022
Q1 | $2.64M | Sell |
20,245
-11,049
| -35% | -$1.44M | 0.04% | 313 |
|
2021
Q4 | $4.78M | Sell |
31,294
-288
| -0.9% | -$44K | 0.07% | 257 |
|
2021
Q3 | $5.11M | Sell |
31,582
-7,586
| -19% | -$1.23M | 0.08% | 244 |
|
2021
Q2 | $6.41M | Buy |
39,168
+873
| +2% | +$143K | 0.09% | 228 |
|
2021
Q1 | $5.77M | Buy |
38,295
+1,344
| +4% | +$202K | 0.09% | 235 |
|
2020
Q4 | $5.6M | Buy |
36,951
+1,160
| +3% | +$176K | 0.09% | 222 |
|
2020
Q3 | $4.85M | Sell |
35,791
-375
| -1% | -$50.8K | 0.09% | 205 |
|
2020
Q2 | $4.94M | Buy |
36,166
+25
| +0.1% | +$3.42K | 0.1% | 198 |
|
2020
Q1 | $3.89M | Buy |
36,141
+16,141
| +81% | +$1.74M | 0.1% | 199 |
|
2019
Q4 | $2.41M | Buy |
+20,000
| New | +$2.41M | 0.04% | 337 |
|